DCF — TOURO INFIRMARY
Enterprise Value: $-262.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-262.2M
Enterprise Value
$-90.2M
PV of Cash Flows
$-172.0M
PV of Terminal Value
$-277.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $380.5M | $-12.4M | -3.0% | $-28.5M | $-25.9M |
| Year 2 | $391.9M | $-8.8M | -2.0% | $-25.4M | $-21.0M |
| Year 3 | $403.7M | $-5.0M | -1.0% | $-22.1M | $-16.6M |
| Year 4 | $415.8M | $-3.1M | -1.0% | $-20.7M | $-14.1M |
| Year 5 | $428.3M | $-2.1M | -0.0% | $-20.3M | $-12.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-262.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$369.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03748900433083376
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5